France Biotech’s expert group examines startup studios as an increasingly important route for accelerating HealthTech innovation, with lessons for founders, investors, academia, pharma, and policymakers.

France Biotech’s annual review of the French HealthTech sector in 2025: a structurally resilient industry facing tighter funding, regulatory and market-access conditions.